Skip to main content
Produced by W2D1 Media. Work with us →

About Michael Winlo

Dr Michael Winlo is Founder and Chief Scientific Officer of Emyria, the ASX-listed company behind the Empax network of clinics that help evaluate psychedelic-assisted therapies for post-traumatic stress disorder and treatment-resistant depression. He also oversees the company's research and drug discovery programs.

A medical graduate of the University of Western Australia with an MBA from Stanford, he holds patents in health data analysis. He spent four years growing the health practice of Palantir Technologies in Silicon Valley and New York, then from 2016 led Linear Clinical Research, the clinical trials arm of Perth's Harry Perkins Institute of Medical Research, before founding Emyria in 2019 (initially called Emerald Clinics). On What The Health with Emily Casey, he explained how psychedelic medicine is moving from counterculture to clinical treatment.

In conversation.

1 episode

Go straight to the good bits.

Key moments from The Psychedelic Resurgence: From Counterculture to Clinical Breakthrough with Dr Michael Winlo.

  1. 0:00Psychedelics return to healthcare
  2. 0:57What Emyria and the Empax clinics do
  3. 2:08From medicine to Palantir and back to Perth
  4. 8:32Why mental health care is falling behind
  5. 12:37What psychedelics actually are
  6. 13:55How MDMA-assisted therapy works
  7. 17:44Psilocybin and the default mode network
  8. 21:05A century of history: from Merck to the war on drugs
  9. 24:18The revival: MAPS, new trials and Australia's rescheduling
  10. 27:17Why psychiatry innovates slowly

The path so far.

  1. Now

    Chief Scientific Officer · Emyria

  2. Until 2019 · Scale-up

    CEO · Linear Clinical Research

  3. Earlier · Scale-up

    Health Lead · Palantir Technologies

  4. Earlier · Startup

    Founding CEO · Cerulean Medical

Sources: rocketreach.co

Emyria on Day One

Emyria (ASX:EMD) is a Perth-based, ASX-listed biotech developing treatments for mental health and neurological conditions, including psychedelic-assisted therapies…

1 person · 1 episode
Emyria

Across the network.

Spot something wrong? Suggest a correctionUpdated 10 November 2026

Put your brand alongside the voices founders, investors and operators come to hear.

Explore sponsorship

One useful lesson,
once a month.

Get conversations and practical lessons from the founders, investors and operators on Day One.

Free. Unsubscribe anytime.

Produced by W2D1 Media

Want a show of your own?

W2D1 Media — the team behind the Day One Network, which helped build Blackbird Ventures' Wild Hearts — builds and produces podcasts for funds, founders and operators. If you want a show built around your brand, let's talk.

Start a show →